MedTrace Logo

Measuring Non-Enhancing Glioblastoma Progression

NCT00777686 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2012-03-30

No results posted yet for this study

Summary

The goal of this clinical research study is to learn if magnetic resonance imaging with magnetic resonance spectroscopy ("MRI/MRS" scanning) can measure any extra growth in the tumor that does not show up on regular MRI images. This study procedure will be performed on patients with recurrent glioblastoma who are either being treated with chemotherapy that blocks blood vessel growth, or will soon begin this type of chemotherapy.

Conditions

Interventions

PROCEDURE

MRI/MRS Scan

MRI/MRS brain scan with intravenous contrast prior to chemotherapy, then repeated every 8 weeks.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • John DeGroot, MD · UT MD Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00777686 on ClinicalTrials.gov